Detalhe da pesquisa
1.
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Cell;
187(7): 1617-1635, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38552610
2.
A neutrophil response linked to tumor control in immunotherapy.
Cell;
186(7): 1448-1464.e20, 2023 03 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37001504
3.
Strength in numbers: predicting response to checkpoint inhibitors from large clinical datasets.
Cell;
184(3): 571-573, 2021 02 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33508231
4.
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
Br J Cancer;
2024 Jun 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38866964
5.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet;
402(10400): 451-463, 2023 08 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37423228
6.
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial.
Lancet;
401(10378): 733-746, 2023 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36764316
7.
[Oncology: what's new in 2023]. / Oncologie: ce qui a changé en 2023.
Rev Med Suisse;
20(856-7): 80-87, 2024 Jan 17.
Artigo
em Francês
| MEDLINE
| ID: mdl-38231107
8.
The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies.
Cancer Invest;
41(6): 571-592, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37272675
9.
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance.
Br J Clin Pharmacol;
89(5): 1601-1616, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36454221
10.
[Lung cancer screening : towards the implementation of a pilot project in Switzerland]. / Dépistage du cancer pulmonaire : vers l'implémentation d'un projet pilote en Suisse.
Rev Med Suisse;
19(850): 2165-2171, 2023 Nov 15.
Artigo
em Francês
| MEDLINE
| ID: mdl-37966148
11.
[Oncology: what's new in 2022]. / Oncologie : ce qui a changé en 2022.
Rev Med Suisse;
19(N° 809-10): 52-57, 2023 Jan 18.
Artigo
em Francês
| MEDLINE
| ID: mdl-36660838
12.
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial.
Contemp Oncol (Pozn);
27(4): 217-223, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38405208
13.
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol;
23(10): 1274-1286, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36108662
14.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet;
397(10272): 375-386, 2021 01 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33485464
15.
Adjuvant Alectinib in ALK-Rearranged NSCLC - Here and Now.
N Engl J Med;
390(14): 1325-1327, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38598800
16.
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
N Engl J Med;
381(21): 2020-2031, 2019 11 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31562796
17.
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Cancer Immunol Immunother;
71(2): 251-265, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34125345
18.
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol;
35(12): 1888-1899, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36115922
19.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
J Transl Med;
20(1): 391, 2022 09 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36058945
20.
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.
Eur J Cancer Care (Engl);
31(6): e13705, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36130722